Log in to your IBTimes Account

close
ID
Password

Dr. Reddy's Laboratories inks global distribution deal with Albemarle Corp. for Ibuprofen API



By Staff Reporter
08 July 2008 @ 11:14 pm IST

Hyderabad - India's second largest pharmaceutical company in terms of sales, Dr. Reddy's Laboratories, said, Tuesday, it has signed a global distribution agreement for painkiller and anti-inflammatory drug Ibuprofen API with Albemarle Corporation.


Ibuprofen
India's second largest pharmaceutical company in terms of sales, Dr. Reddy's Laboratories, said, Tuesday, it has signed a global distribution agreement for painkiller and anti-inflammatory drug Ibuprofen API with Albemarle Corporation.
1 of 1

advertisement

According to the deal, the Louisiana-based specialty chemicals company shall supply Ibuprofen API from its Orangeburg plant in South Carolina, US, to Dr. Reddy's for distribution to its global client base.

Financial details of the deal were not disclosed.

"Ibuprofen is used for the management of pain, fever, and inflammation and its market size is estimated at US$2.24 billion globally," the Indian drug maker said in a regulatory filing.

This article is copyrighted by Ibtimes.co.in.

    Click!
  • Rate this article:

Comments

Post Your Comment

You must be an IBTimes member to post a comment. Login | Register


advertisement
More Companies News
Bharti Airtel's board will on Saturday discuss its $9 billion bid for Kuwaiti telecom group Zain's African units, a source said, and the two sides may cl...
South Korea's Samsung Electronics Co. Ltd. is targeting a higher operating profit and double-digit growth in sales in 2010, fuelled by strong demand for ...
Telecoms firms including Bharti Airtel, Vodafone and Etisalat will vie for third-generation (3G) Indian mobile spectrum in an April auction, as they clam...

advertisement
 
IBTimes.co.in Web
 
International Business Times© 2010 The Ibtimes Company. All Rights Reserved. Partners